{"database": "lobbying", "table": "lobbying_activities", "rows": [[2511582, "477d1e44-3018-4e5d-9837-4a3485169a6c", "Q3", "SAFEWAY INC.", 300173, "SAFEWAY", 2020, "third_quarter", "PHA", "CMS Medicaid Part D Final Rule, provisions related to DIR Fees\n\nH.R. 1034, S. 640 - Phair Pricing Act, all provisions\n\nH.R. 1614, S. 724 - John S. McCain Opioid Addiction Prevention Act, all provisions\n\nIssues related to pharmacist provider status\n\nS 2543 - Prescription Drug Pricing Reduction Act of 2019 - provisions related to Medicare Part D drug pricing.\n\n\nHHS Proposed Rule - Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees", "HOUSE OF REPRESENTATIVES,SENATE", null, 90000, 0, 0, "2020-10-16T15:09:43.717000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2511582"], "units": {}, "query_ms": 137.72026100195944, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}